Bristol-Myers said that the EMA's Committee for Medicinal Products for Human Use granted positive opinions for the company's treatments for hepatitis C, and deep vein thrombosis and pulmonary embolism.
via WSJ.com: US Business http://ift.tt/1jV1qDq
via WSJ.com: US Business http://ift.tt/1jV1qDq
Nessun commento:
Posta un commento